Contepo FDA Approval Status
FDA Approved: No
Brand name: Contepo
Generic name: fosfomycin
Company: Nabriva Therapeutics plc
Treatment for: Urinary Tract Infection
Contepo (fosfomycin for injection) is an investigational epoxide antibiotic in development as a first-line treatment for complicated urinary tract infections (cUTIs), including acute pyelonephritis.
Development timeline for Contepo
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.